Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matti Waterman

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Journal of Clinical Gastroenterology|December 4, 2013
Recurrent small intestinal ileus secondary to valsartan treatmentTarek Saadi, Rita Brun, Yehuda Chowers, et al.
International Journal of Colorectal Disease|January 14, 2020
Does early corticosteroid therapy affect prognosis in IBD patients hospitalized with Clostridioides difficile infection?Haggai Bar-Yoseph, Haneen Daoud, Dana Ben Hur, et al.
Harefuah|December 23, 2006
[The significance of IL-13 gene +2044G/A mutation in patients with inflammatory bowel disease]Matti Waterman, Amir Karban, Shula Nesher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 17, 2006
Heparanase upregulation by colonic epithelium in inflammatory bowel diseaseMatti Waterman, Ofer Ben-Izhak, Rami Eliakim, et al.
Journal of Gastroenterology and Hepatology|July 22, 2014
Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitisDavid Kevans, Matti Waterman, Raquel Milgrom, et al.
Health and Quality of Life Outcomes|January 13, 2023
Implementing electronic patient reported outcomes in inflammatory bowel disease: patient participation, score reliability and validityDaniel Deutscher, Clara Weil, Gabriel Chodick, et al.
BMC Gastroenterology|August 18, 2025
Mesenteric fat proliferation on magnetic resonance enterography is a predictor of long-term disease complications in crohn's diseaseEduard Koifman, Inna Spector Cohen, Rebeca Lopez-Alonso, et al.
Digestive Diseases and Sciences|April 17, 2007
Paraoxonase (PON)1 192R allele carriage is associated with reduced risk of inflammatory bowel diseaseAmir Karban, Corina Hartman, Rami Eliakim, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 15, 2009
Heparanase expression by Barrett's epithelium and during esophageal carcinoma progressionRita Brun, Inna Naroditsky, Matti Waterman, et al.
Human Pathology|July 16, 2014
Distinctive histopathologic phenotype in resection specimens from patients with Crohn's disease receiving anti-TNF-α therapyDavid F Schaeffer, Joanna C Walsh, Richard Kirsch, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Journal of Clinical Gastroenterology|December 4, 2013
Recurrent small intestinal ileus secondary to valsartan treatmentTarek Saadi, Rita Brun, Yehuda Chowers, et al.
International Journal of Colorectal Disease|January 14, 2020
Does early corticosteroid therapy affect prognosis in IBD patients hospitalized with Clostridioides difficile infection?Haggai Bar-Yoseph, Haneen Daoud, Dana Ben Hur, et al.
Harefuah|December 23, 2006
[The significance of IL-13 gene +2044G/A mutation in patients with inflammatory bowel disease]Matti Waterman, Amir Karban, Shula Nesher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 17, 2006
Heparanase upregulation by colonic epithelium in inflammatory bowel diseaseMatti Waterman, Ofer Ben-Izhak, Rami Eliakim, et al.
Journal of Gastroenterology and Hepatology|July 22, 2014
Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitisDavid Kevans, Matti Waterman, Raquel Milgrom, et al.
Health and Quality of Life Outcomes|January 13, 2023
Implementing electronic patient reported outcomes in inflammatory bowel disease: patient participation, score reliability and validityDaniel Deutscher, Clara Weil, Gabriel Chodick, et al.
BMC Gastroenterology|August 18, 2025
Mesenteric fat proliferation on magnetic resonance enterography is a predictor of long-term disease complications in crohn's diseaseEduard Koifman, Inna Spector Cohen, Rebeca Lopez-Alonso, et al.
Digestive Diseases and Sciences|April 17, 2007
Paraoxonase (PON)1 192R allele carriage is associated with reduced risk of inflammatory bowel diseaseAmir Karban, Corina Hartman, Rami Eliakim, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 15, 2009
Heparanase expression by Barrett's epithelium and during esophageal carcinoma progressionRita Brun, Inna Naroditsky, Matti Waterman, et al.
Human Pathology|July 16, 2014
Distinctive histopathologic phenotype in resection specimens from patients with Crohn's disease receiving anti-TNF-α therapyDavid F Schaeffer, Joanna C Walsh, Richard Kirsch, et al.
Pageof 5